(Q42605432)
Statements
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia (English)
Michael F Drummond
Debbie L Becker
Margaret Hux
Isabelle Duprat-Lomon
Rolf Kubin
Pierre-Philippe Sagnier
1 August 2003